世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035676

炎症性腸疾患の世界市場(2023-2027)

TechNavio

Global Inflammatory Bowel Disease Market 2023-2027

発刊日 2023/06/12

言語英語

体裁PDF/165ページ

ライセンス/価格165ページ

0000035676

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

炎症性腸疾患(IBD)市場は、2022年から2027年の間に76億8,743万米ドル成長し、予測期間中に5.77 %のCAGRで加速すると予測されています。炎症性腸疾患市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題に加えて、約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。この市場を牽引しているのは、世界的なIBD罹患率の増加、生物学的製剤や標的治療薬に対する需要の増加、IBDに対する意識の高まりです。

調査範囲

  • 市場セグメント
    ➣ 流通チャネル別
      ◇ オフライン
      ◇ オンライン
    ➣ タイプ別
      ◇ クローン病
      ◇ 潰瘍性大腸炎
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

この調査は、IBD治療薬の新発売が今後数年間の炎症性腸疾患市場の成長を促進する主な理由の1つであることを特定しています。また、世界のIBD市場におけるIBD関連の調査研究や合併・買収への資金提供は、市場でのかなりの需要につながるでしょう。

炎症性腸疾患市場に関するレポートは、次の分野をカバーしています。

  • 炎症性腸疾患市場の規模
  • 炎症性腸疾患市場の予測
  • 炎症性腸疾患市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、炎症性腸疾患市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ AbbVie Inc.
    ➣ AstraZeneca
    ➣ Aurobindo Pharma Ltd.
    ➣ Bausch Health Co. Inc.
    ➣ Baxter International Inc.
    ➣ Bayer AG
    ➣ Biocon Ltd.
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ GlaxoSmithKline Plc
    ➣ Lupin Ltd., Merck and Co. Inc.
    ➣ Novartis AG
    ➣ Pfizer Inc.
    ➣ Sanofi
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.
    ➣ Johnson and Johnson Services Inc.

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global inflammatory bowel disease market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global inflammatory bowel disease market 2017 - 2021 ($ million)
4.2 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Offline - Market size and forecast 2022-2027
Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
6.4 Online - Market size and forecast 2022-2027
Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Distribution Channel
Exhibit 42: Market opportunity by Distribution Channel ($ million)
Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 44: Chart on Type - Market share 2022-2027 (%)
Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
7.3 Crohn disease - Market size and forecast 2022-2027
Exhibit 48: Chart on Crohn disease - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Crohn disease - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Crohn disease - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Crohn disease - Year-over-year growth 2022-2027 (%)
7.4 Ulcerative colitis - Market size and forecast 2022-2027
Exhibit 52: Chart on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 56: Market opportunity by Type ($ million)
Exhibit 57: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 83: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 India - Market size and forecast 2022-2027
Exhibit 91: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on India - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 AstraZeneca
Exhibit 107: AstraZeneca - Overview
Exhibit 108: AstraZeneca - Product / Service
Exhibit 109: AstraZeneca - Key news
Exhibit 110: AstraZeneca - Key offerings
12.4 Aurobindo Pharma Ltd.
Exhibit 111: Aurobindo Pharma Ltd. - Overview
Exhibit 112: Aurobindo Pharma Ltd. - Product / Service
Exhibit 113: Aurobindo Pharma Ltd. - Key offerings
12.5 Baxter International Inc.
Exhibit 114: Baxter International Inc. - Overview
Exhibit 115: Baxter International Inc. - Business segments
Exhibit 116: Baxter International Inc. - Key news
Exhibit 117: Baxter International Inc. - Key offerings
Exhibit 118: Baxter International Inc. - Segment focus
12.6 Bayer AG
Exhibit 119: Bayer AG - Overview
Exhibit 120: Bayer AG - Business segments
Exhibit 121: Bayer AG - Key news
Exhibit 122: Bayer AG - Key offerings
Exhibit 123: Bayer AG - Segment focus
12.7 Eli Lilly and Co.
Exhibit 124: Eli Lilly and Co. - Overview
Exhibit 125: Eli Lilly and Co. - Product / Service
Exhibit 126: Eli Lilly and Co. - Key news
Exhibit 127: Eli Lilly and Co. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 133: GlaxoSmithKline Plc - Overview
Exhibit 134: GlaxoSmithKline Plc - Business segments
Exhibit 135: GlaxoSmithKline Plc - Key news
Exhibit 136: GlaxoSmithKline Plc - Key offerings
Exhibit 137: GlaxoSmithKline Plc - Segment focus
12.10 Johnson and Johnson Services Inc.
Exhibit 138: Johnson and Johnson Services Inc. - Overview
Exhibit 139: Johnson and Johnson Services Inc. - Business segments
Exhibit 140: Johnson and Johnson Services Inc. - Key news
Exhibit 141: Johnson and Johnson Services Inc. - Key offerings
Exhibit 142: Johnson and Johnson Services Inc. - Segment focus
12.11 Merck and Co. Inc.
Exhibit 143: Merck and Co. Inc. - Overview
Exhibit 144: Merck and Co. Inc. - Business segments
Exhibit 145: Merck and Co. Inc. - Key news
Exhibit 146: Merck and Co. Inc. - Key offerings
Exhibit 147: Merck and Co. Inc. - Segment focus
12.12 Novartis AG
Exhibit 148: Novartis AG - Overview
Exhibit 149: Novartis AG - Business segments
Exhibit 150: Novartis AG - Key offerings
Exhibit 151: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 152: Pfizer Inc. - Overview
Exhibit 153: Pfizer Inc. - Product / Service
Exhibit 154: Pfizer Inc. - Key news
Exhibit 155: Pfizer Inc. - Key offerings
12.14 Sanofi
Exhibit 156: Sanofi - Overview
Exhibit 157: Sanofi - Business segments
Exhibit 158: Sanofi - Key news
Exhibit 159: Sanofi - Key offerings
Exhibit 160: Sanofi - Segment focus
12.15 Sun Pharmaceutical Industries Ltd.
Exhibit 161: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 162: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 163: Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 169: Viatris Inc. - Overview
Exhibit 170: Viatris Inc. - Business segments
Exhibit 171: Viatris Inc. - Key news
Exhibit 172: Viatris Inc. - Key offerings
Exhibit 173: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 174: Inclusions checklist
Exhibit 175: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 176: Currency conversion rates for US$
13.4 Research methodology
Exhibit 177: Research methodology
Exhibit 178: Validation techniques employed for market sizing
Exhibit 179: Information sources
13.5 List of abbreviations
Exhibit 180: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global inflammatory bowel disease market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits44: Chart on Type - Market share 2022-2027 (%)
Exhibits45: Data Table on Type - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Crohn disease - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Crohn disease - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Crohn disease - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Crohn disease - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Type ($ million)
Exhibits57: Data Table on Market opportunity by Type ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AstraZeneca - Overview
Exhibits108: AstraZeneca - Product / Service
Exhibits109: AstraZeneca - Key news
Exhibits110: AstraZeneca - Key offerings
Exhibits111: Aurobindo Pharma Ltd. - Overview
Exhibits112: Aurobindo Pharma Ltd. - Product / Service
Exhibits113: Aurobindo Pharma Ltd. - Key offerings
Exhibits114: Baxter International Inc. - Overview
Exhibits115: Baxter International Inc. - Business segments
Exhibits116: Baxter International Inc. - Key news
Exhibits117: Baxter International Inc. - Key offerings
Exhibits118: Baxter International Inc. - Segment focus
Exhibits119: Bayer AG - Overview
Exhibits120: Bayer AG - Business segments
Exhibits121: Bayer AG - Key news
Exhibits122: Bayer AG - Key offerings
Exhibits123: Bayer AG - Segment focus
Exhibits124: Eli Lilly and Co. - Overview
Exhibits125: Eli Lilly and Co. - Product / Service
Exhibits126: Eli Lilly and Co. - Key news
Exhibits127: Eli Lilly and Co. - Key offerings
Exhibits128: F. Hoffmann La Roche Ltd. - Overview
Exhibits129: F. Hoffmann La Roche Ltd. - Business segments
Exhibits130: F. Hoffmann La Roche Ltd. - Key news
Exhibits131: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits132: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits133: GlaxoSmithKline Plc - Overview
Exhibits134: GlaxoSmithKline Plc - Business segments
Exhibits135: GlaxoSmithKline Plc - Key news
Exhibits136: GlaxoSmithKline Plc - Key offerings
Exhibits137: GlaxoSmithKline Plc - Segment focus
Exhibits138: Johnson and Johnson Services Inc. - Overview
Exhibits139: Johnson and Johnson Services Inc. - Business segments
Exhibits140: Johnson and Johnson Services Inc. - Key news
Exhibits141: Johnson and Johnson Services Inc. - Key offerings
Exhibits142: Johnson and Johnson Services Inc. - Segment focus
Exhibits143: Merck and Co. Inc. - Overview
Exhibits144: Merck and Co. Inc. - Business segments
Exhibits145: Merck and Co. Inc. - Key news
Exhibits146: Merck and Co. Inc. - Key offerings
Exhibits147: Merck and Co. Inc. - Segment focus
Exhibits148: Novartis AG - Overview
Exhibits149: Novartis AG - Business segments
Exhibits150: Novartis AG - Key offerings
Exhibits151: Novartis AG - Segment focus
Exhibits152: Pfizer Inc. - Overview
Exhibits153: Pfizer Inc. - Product / Service
Exhibits154: Pfizer Inc. - Key news
Exhibits155: Pfizer Inc. - Key offerings
Exhibits156: Sanofi - Overview
Exhibits157: Sanofi - Business segments
Exhibits158: Sanofi - Key news
Exhibits159: Sanofi - Key offerings
Exhibits160: Sanofi - Segment focus
Exhibits161: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits162: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits163: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits165: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits166: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits167: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits168: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits169: Viatris Inc. - Overview
Exhibits170: Viatris Inc. - Business segments
Exhibits171: Viatris Inc. - Key news
Exhibits172: Viatris Inc. - Key offerings
Exhibits173: Viatris Inc. - Segment focus
Exhibits174: Inclusions checklist
Exhibits175: Exclusions checklist
Exhibits176: Currency conversion rates for US$
Exhibits177: Research methodology
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Information sources
Exhibits180: List of abbreviations

この商品のレポートナンバー

0000035676

TOP